Xarelto Lawsuit: The US Case Is Over, Canada Has a Settlement
Questions about this case?
AI Legal Assistant · free · answers in seconds · general information, not legal advice
If you are searching for a Xarelto lawsuit or a class action Xarelto settlement in 2026, the answer depends on where you live. In the United States, Bayer and Johnson & Johnson's Janssen agreed in 2019 to pay $775 million to resolve about 25,000 bleeding-injury lawsuits, and the federal court case, MDL 2592, was closed on February 11, 2026. There is no US claim form and nothing new to join. In Canada, a separate class action settlement of up to $5.25 million (CDN) was approved by courts in May 2026, with claims handled by MNP Ltd.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What the Xarelto Lawsuits Alleged
Xarelto (rivaroxaban) is a blood thinner sold by Bayer and Janssen, a Johnson & Johnson company. The lawsuits alleged the companies failed to warn that the drug can cause potentially fatal bleeding. Plaintiffs claimed bleeding events, strokes and related injuries.
The companies denied the claims and never admitted liability. Before the US settlement, they had won six cases that went to trial. The Canadian defendants also deny wrongdoing; the notices state the allegations have not been proven in court.
Case Details
United States: On December 12, 2014 the Judicial Panel on Multidistrict Litigation consolidated the federal cases as In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592, No. 2:14-md-02592 in the U.S. District Court for the Eastern District of Louisiana, before Judge Eldon E. Fallon. At its peak the MDL held over 30,000 cases. A separate patent fight between the makers and generic companies, MDL 3017 in Delaware, has nothing to do with patients and was also closed in February 2026.
Canada: Tluchak (Estate) et al. v. Bayer Inc. et al., Court of King's Bench for Saskatchewan, Docket QBG-RG-00517-2015, covers Canadians outside Québec. Gagnon vs. Bayer Inc. et al., Superior Court of Québec, court file no. 500-06-000732-152, was authorized as a class action on July 22, 2020 and covers Québec residents.
Status as of October 2026
Canada: settled, claims through MNP. The national Settlement Agreement is dated October 27, 2025. The opt-out and objection deadline was March 10, 2026 and has passed. Court documents list an order approving the settlement dated May 14, 2026 and a Québec judgment approving it dated May 19, 2026. The claim deadline is the end of the “Claim Period” posted on the official site, mnp.ca/xareltosettlement. As of October 2026 we could not confirm that date independently, so check it there before relying on any date you see elsewhere.
Who Is Covered
United States: The 2019 deal was an opt-in program for people who already had a filed or registered lawsuit. Over 99% of plaintiffs in the MDL opted in. If you never filed a claim, you are not part of it, and there is no class to join now.
Canada outside Québec: residents who were prescribed and took Xarelto in Canada on or before October 27, 2025, plus eligible family members.
Québec: residents prescribed and taking Xarelto from January 1, 2008 to October 27, 2025, and their family members.
Being in the class is not enough to be paid. The person who took the drug must have had a bleeding event that caused death, a brain injury or other significant organ damage with long-term impairment, or at least 24 hours in hospital — and must have taken Xarelto within 24 hours before the bleed. Pharmacy and medical records are the proof; records from before November 2023 may show the name rivaroxaban.
How Much the Xarelto Settlements Pay
Canada: a fund of at least $4.5 million and up to $5.25 million (CDN), depending on the number of approved claims. It must also cover provincial health-insurer claims, administration, and class counsel fees sought at $1,350,000 to $1,575,000 plus taxes. What is left is divided by points based on the severity of the bleeding event, so no fixed amount per person exists. The notice states plainly that not all class members will be eligible for compensation. With a fund this size spread across a whole country, expect a modest payment unless your injury was severe.
How cases like this one end
Our copy of the federal courts’ own case database covers 166,050 health care/pharmaceutical product liability casesclosed in U.S. federal district courts between 2015 and 2025:
- 34.5% ended in a settlement recorded by the court. Another 17.9% were dismissed voluntarily, which often follows a private settlement — so the real settlement share sits between 34.5% and 52.4%.
- 9% were decided on a motion before any trial.
- 1 in 2,863 reached a trial (0%), after a median of 32 months.
- Median time from filing to the end of the case: 26.3 months.
- Almost none record a money award in this data (18 of 166,050), and the recorded figures are capped, so we do not publish an average.
These are base rates for this type of case (federal health care/pharmaceutical product liability cases) — not a prediction about this lawsuit, and not legal advice. Source: Federal Judicial Center, Integrated Database (civil), analysed by Settlement Insight. Cases heard in state courts are not included.
Xarelto Litigation Timeline
- 1
December 12, 2014 — Federal Cases Consolidated
The JPML creates MDL 2592 in the Eastern District of Louisiana before Judge Eldon E. Fallon. Cases eventually top 30,000.
- 2
March 25, 2019 — $775 Million US Settlement
After six bellwether trials in federal and Pennsylvania courts, Bayer and Janssen announce an opt-in deal for about 25,000 lawsuits, without admitting liability.
- 3
August 5, 2019 — US Enrollment Closes
Plaintiffs had to enroll through the BrownGreer MDL Centrality portal by this date. The defendants fully funded the settlement by January 17, 2020.
- 4
October 27, 2025 — Canadian Settlement Signed
The Saskatchewan and Québec class actions settle together for up to $5.25 million (CDN), subject to court approval in both provinces.
- 5
February 11, 2026 — MDL 2592 Terminated
The JPML lists the US Xarelto product-liability MDL as closed. The separate patent MDL 3017 closed on February 3, 2026.
- 6
May 2026 — Canadian Settlement Approved
Approval orders are dated May 14 and May 19, 2026. Claims go to MNP Ltd. within the Claim Period posted on the official settlement site.
Three Things to Watch For
A closed US case and a small Canadian fund still draw people who want your records or your money:
“Join the Xarelto class action” ads in the US
There is no open US Xarelto class action or claim form; the MDL closed on February 11, 2026. An ad promising a share of the $775 million is collecting your health information, not filing a claim.
Fees to file a Canadian claim
The only claims administrator is MNP Ltd., and the claim form comes from mnp.ca/xareltosettlement. Nobody legitimate charges you to submit it or asks for banking details before a claim is approved.
Callers asking for your full medical file
The Canadian claim needs records of the prescription and the bleeding event, sent to the administrator. A stranger who calls offering to “handle” your Xarelto claim and wants your health card number or a signed medical release should be treated as a phishing attempt.
Xarelto Lawsuit — Questions People Actually Ask
Is there a Xarelto class action lawsuit I can join in 2026?
Not in the US. If you searched for a class action lawsuit Xarelto patients could join, the American cases were individual lawsuits grouped in MDL 2592, resolved by the $775 million settlement in 2019, and the MDL was closed on February 11, 2026. In Canada there is a settled class action — Tluchak in Saskatchewan and Gagnon in Québec — and eligible people can claim through MNP Ltd.
What was the class action lawsuit against Xarelto about?
The lawsuits alleged Bayer and Janssen failed to warn that Xarelto can cause serious, sometimes fatal bleeding. The companies denied this, won the six cases that went to trial, and settled without admitting liability.
How much was the US Xarelto settlement?
$775 million, announced March 25, 2019, covering about 25,000 lawsuits, with Bayer and Johnson & Johnson each paying half. A settlement special master devised the protocol for distributing the proceeds; we found no published list of individual payments.
I took Xarelto in the US and had a bleed. Can I still file a lawsuit against Xarelto?
The settlement program closed to enrollment on August 5, 2019, and the MDL is terminated. Any new individual claim would depend on your state's filing deadlines, which have likely run for older injuries. Only a licensed attorney in your state can assess that.
Who qualifies for the Canadian Xarelto settlement?
Canadian residents prescribed and taking Xarelto on or before October 27, 2025 (in Québec, from January 1, 2008), plus family members. To be paid, the person must have had a qualifying bleeding event — death, brain injury or organ damage with lasting impairment, or at least 24 hours in hospital — within 24 hours of taking the drug.
What is the deadline for a Canadian Xarelto claim?
The deadline is the end of the Claim Period posted on mnp.ca/xareltosettlement. The opt-out and objection deadline was March 10, 2026 and has passed; class members who did not opt out cannot sue separately over these allegations.
How much will a Canadian claimant get?
There is no fixed amount. The fund is $4.5 million to $5.25 million (CDN) before fees and costs, and the rest is split by points according to how severe the bleeding injury was. Not everyone in the class qualifies.
Is a Xarelto settlement letter or email real?
For Canada, compare it with mnp.ca/xareltosettlement and contact MNP Ltd. directly using the details listed there, not the ones in the message. Any US message saying you are owed money from a new Xarelto class action is not from a court-appointed administrator.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.
Related Consumer Brand Lawsuits
Open Class Action Settlements
Settlements currently accepting claims, with deadlines
Zantac Lawsuit Status
Another drug mass tort: where those cases stand
Johnson & Johnson Talc Settlement
The other big J&J product-liability fight
Settlement Payout Calculator
Estimate what a class settlement share might be worth